Articles
| Open Access |
DOI: AI-Powered Failure Mode and Effects Analysis (FMEA) for Cardiovascular Devices: A Modern Framework for Proactive Risk Management
Aniruddha Dhole , Design Quality Assurance , USAAbstract
Stents and implantable defibrillators are examples of cardiovascular equipment that keep people alive. The safety and dependability of these devices are very important. The Conventional Failure Mode and Effects Analysis (FMEA) methods are well recognized, and they tend to be subjective, reactive, and highly dependent on the past and human knowledge. This paper explores how the Failure Mode and Effects Analysis (FMEA) process of cardiovascular devices can be enhanced with the help of Artificial Intelligence (AI), namely, natural language processing (NLP), machine learning (ML), and predictive analytics. We suggest a modern FMEA framework that uses AI to accurately find possible failure modes and automatically update risk profiles using real-time data from clinical trials, manufacturing, and post-market surveillance. The objective is to demonstrate that AI-enhanced FMEA can transform device design and manufacturing into a more proactive, data-informed safety framework.
Keywords
AI, FMEA, Cardiovascular Devices, Risk Management, Predictive Analytics, NLP, Medical Device Reliability, Failure Modes
References
Zhang, Y., Jiang, H., Liu, F,” Application of Machine Learning Algorithms in FMEA for Medical Devices. Artificial Intelligence in Medicine”, PP 114:102038, (2021) https://doi.org/10.1016/j.artmed.2021.102038
Natarajan, S., et al, “AI in Cardiovascular Healthcare: Applications, Challenges and Perspectives Journal of the American College of Cardiology: Cardiovascular Imaging”,PP14(3):678–692,(2021) https://doi.org/10.1016/j.jcmg.2020.09.025
Rajkomar, A., et al.” Machine Learning in Healthcare. New England Journal of Medicine”,PP380(14):1347-1358,(2019) https://doi.org/10.1056/NEJMra1814259
Chen, I.Y., Joshi, S., Ghassemi, M.” Treating Health Disparities with Artificial Intelligence.NatureMedicine”,PP26:16–17,(2020) https://doi.org/10.1038/s41591-019-0649-2
Wiegmann, D.A., et al.”A Cognitive Systems Engineering Approach to the Integration of Artificial Intelligence into the FMEA Process. Systems Engineering”,PP25(1):56–67,(2022) https://doi.org/10.1002/sys.21529
Topol, E,” High-Performance Medicine: The Convergence of Human and Artificial Intelligence.NatureMedicine”,PP25(1):44–56.(2019) https://doi.org/10.1038/s41591-018-0300-7
Sarker, I.H.,”Machine Learning: Algorithms, Real-World Applications and ResearchDirections.SNComputerScience”,PP2(3):160.(2021) https://doi.org/10.1007/s42979-021-00592-x
International Organization for Standardization (ISO). ISO 14971:2019 - Medical devices — Application of risk management to medical devices. Geneva: ISO; 2019. https://www.iso.org/standard/72704.html
U.S. Food & Drug Administration (FDA). Total Product Life Cycle (TPLC) Approach to Medical Device Safety.
https://www.fda.gov/medical-devices/total-product-life-cycle
Download and View Statistics
Copyright License
Copyright (c) 2025 Aniruddha Dhole
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.